Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Cancer Type/Condition:  Oropharyngeal cancer
Trial Type:  Prevention
Trial Status:  Closed
Sponsor of Trial:  NCI
Results 1-25 of 25 for your search:
Start Over
Phase III Chemoprevention Study of Low-Dose 13-Cis-Retinoic Acid for Second Primary Tumors in Patients with Head and Neck Cancer
Phase: Phase III
Type: Prevention
Status: Completed
Age: 18 to 74
Sponsor: NCI
Protocol IDs: RTOG-9115, CLB-9499, SWOG-9446, MDA-CCOP-DM-90094, NCI-P91-0024, NCI-C91-0002, RTOG-91-15, MDA-C91-0002
Phase III Randomized Placebo-Controlled Study of Beta Carotene for Chemoprevention of Second Primaries in Patients with Stage I/II Head and Neck Cancer
Phase: Phase III
Type: Prevention
Status: Closed
Age: adult
Sponsor: NCI
Protocol IDs: SWOG-9043, NCI-P93-0039
Gene Therapy in Preventing Cancer in Patients With Premalignant Carcinoma of the Oral Cavity or Pharynx
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02541, MDA-ID-00193, P50CA097007, CDR0000306522, NCI-6053, 6053, NCT00064103
Phase I/II Study of Chemoprevention With EGFR and COX-2 Inhibitor
Phase: Phase II, Phase I
Type: Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: IRB00024922, NCT00314262
Zileuton With or Without Celecoxib As Chemopreventive Agents in Smokers
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2013-00730, 2009-0804, N01CN35159, NCT01021215
Exercise, Smoking Cessation and Adolescents
Phase: Phase II, Phase I
Type: Behavioral study, Prevention
Status: Closed
Age: 13 to 19
Sponsor: NCI, Other
Protocol IDs: R03-CA119712, NCT00297440
Phase II Chemoprevention of Head and Neck Cancer by Acetylcysteine (Summary Last Modified 05/98)
Phase: Phase II
Type: Prevention
Status: Completed
Age: Over 18
Sponsor: NCI
Protocol IDs: GUMC-19196, NCI-P97-0118
Phase II Study of Adjuvant Biologic Therapy for Preventing Recurrence and Second Primary Tumors in Patients with Stage III or IV Squamous Cell Cancer of the Head and Neck
Phase: Phase II
Type: Prevention, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MDA-ID-95015, NCI-H98-0011
Phase IIB Randomized Chemoprevention Study of Ketorolac Mouth Rinse in Patients With Oropharyngeal Leukoplakia
Phase: Phase II
Type: Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-98-C-0118
Celecoxib in Preventing Cancer in Patients With Oral Leukoplakia and/or Head and Neck Dysplasia
Phase: Phase II
Type: Prevention
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000258562, DFCI-02024, DFCI-2002-P-00150/2, NCT00052611
Zileuton in Preventing Lung Cancer in Patients With Bronchial Dysplasia
Phase: Phase II
Type: Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000271915, P30CA022453, WSU-D-2405, WSU-093201MP4F, NCT00056004
Celecoxib in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia
Phase: Phase II
Type: Health services research, Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: FCCC-02028, CDR0000393574, NCT00101335
Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Patients With Oral Leukoplakia
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00888, 98-34, U01CA072294, UCIRVINE-UCI-98-34, UCIRVINE-UCI-1998-521, U01-CA-72294, NCT00330382
Zinc Supplements in Lowering Cadmium Levels in Smokers
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Closed
Age: 21 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000495325, CCCWFU-98903, CCCWFU-BG03-538, NCT00376987
Rosiglitazone Maleate in Treating Patients With Oral Leukoplakia
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02968, 2005-0485, N01CN35159, P30CA008748, P30CA016672, MSKCC-05062, MDA-2005-0485, MDA04-2-02, NCT00369174
Phase I Randomized Study of Tretinoin in Patients With Previously Treated Squamous Cell Carcinoma of the Head and Neck
Phase: Phase I
Type: Prevention, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UMCC-9212, NCI-T92-0121C, T92-0121
PROS Smokebusters: Adolescent Smoking Cessation in Pediatric Primary Care
Phase: Phase I
Type: Behavioral study, Prevention
Status: Completed
Age: 14 and over
Sponsor: NCI, Other
Protocol IDs: 15677, NCT00135265
House Officers Training in Smoking Cessation (Summary Last Modified 11/91)
Phase: No phase specified
Type: Prevention
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: CLB-9071, NCI-P91-0007
Internet and Telephone Counseling for Smoking Cessation
Phase: No phase specified
Type: Behavioral study, Health services research, Prevention
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000465179, R01CA104836, GUMC-5-R01CA104836, RWMC-5-R01CA104836, NCT00282009
Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking
Phase: No phase specified
Type: Behavioral study, Biomarker/Laboratory analysis, Educational/Counseling/Training, Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: 10332, R01CA091912, KUMC-HSC-10332, KUMC-070313, NCT00666978
Assessment of a Teachable Moment for Smoking Cessation
Phase: No phase specified
Type: Behavioral study, Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 805712, NIH R01CA126969, NCT00596440
Combined Treatment for Tobacco and Alcohol Use in Puerto Rico
Phase: No phase specified
Type: Behavioral study, Prevention
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 2005-0791, U54 CA 96300, U54 CA 96297, NCI-2012-02110, NCT00570804
Smoking Cessation for HIV/AIDS Patients
Phase: No phase specified
Type: Behavioral study, Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 2003-0784, NCI-2012-02109, NCT00502827
Increasing Contingency Management Success in Smoking Cessation
Phase: No phase specified
Type: Behavioral study, Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 045-0013-195, R01DA013304, NCT00273793
Start Over